AU2001274407A1 - Benzophenones and sulfones as inhibitors of glycine uptake - Google Patents
Benzophenones and sulfones as inhibitors of glycine uptakeInfo
- Publication number
- AU2001274407A1 AU2001274407A1 AU2001274407A AU7440701A AU2001274407A1 AU 2001274407 A1 AU2001274407 A1 AU 2001274407A1 AU 2001274407 A AU2001274407 A AU 2001274407A AU 7440701 A AU7440701 A AU 7440701A AU 2001274407 A1 AU2001274407 A1 AU 2001274407A1
- Authority
- AU
- Australia
- Prior art keywords
- benzophenones
- sulfones
- inhibitors
- glycine uptake
- uptake
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21569200P | 2000-06-30 | 2000-06-30 | |
US60215692 | 2000-06-30 | ||
PCT/IB2001/001139 WO2002000602A1 (en) | 2000-06-30 | 2001-06-22 | Benzophenones and sulfones as inhibitors of glycine uptake |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001274407A1 true AU2001274407A1 (en) | 2002-01-08 |
Family
ID=22803976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001274407A Abandoned AU2001274407A1 (en) | 2000-06-30 | 2001-06-22 | Benzophenones and sulfones as inhibitors of glycine uptake |
Country Status (17)
Country | Link |
---|---|
US (1) | US6506780B2 (en) |
EP (1) | EP1294677B1 (en) |
JP (1) | JP3801561B2 (en) |
AP (1) | AP2001002203A0 (en) |
AR (1) | AR033828A1 (en) |
AT (1) | ATE281427T1 (en) |
AU (1) | AU2001274407A1 (en) |
DE (1) | DE60106914T2 (en) |
DK (1) | DK1294677T3 (en) |
DO (1) | DOP2001000189A (en) |
ES (1) | ES2230326T3 (en) |
PA (1) | PA8519901A1 (en) |
PE (1) | PE20020121A1 (en) |
PT (1) | PT1294677E (en) |
TN (1) | TNSN01098A1 (en) |
UY (1) | UY26802A1 (en) |
WO (1) | WO2002000602A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566550B2 (en) | 2001-06-21 | 2003-05-20 | Pfizer Inc | Substituted aromatic ethers as inhibitors of glycine transport |
IL154318A (en) * | 2003-02-06 | 2010-05-31 | Sarah Herzog Memorial Hospital | Pharmaceutical compositions for the treatment of movement disorders |
AU2004233942A1 (en) * | 2003-04-30 | 2004-11-11 | H. Lundbeck A/S | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
KR20060066729A (en) * | 2003-08-21 | 2006-06-16 | 하. 룬트벡 아크티에 셀스카브 | The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
WO2005100301A1 (en) * | 2004-03-31 | 2005-10-27 | Eli Lilly And Company | 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors |
CA2601326A1 (en) * | 2005-01-18 | 2006-07-27 | F.Hoffmann-La Roche Ag | 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1(glyt-i) inhibitors for the treatment of neurological and neuropsychiatric disorders |
RS51204B (en) | 2005-02-07 | 2010-12-31 | F. Hoffmann-La Roche Ag. | Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
US20100016374A1 (en) * | 2006-04-05 | 2010-01-21 | Steven Coulton | Compounds Which Inhibit the Glycine Transporter and Uses Thereof |
EP2699543B1 (en) * | 2011-04-19 | 2016-03-02 | Integrative Research Laboratories Sweden AB | Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission |
JP5761444B2 (en) | 2012-03-01 | 2015-08-12 | トヨタ自動車株式会社 | Body structure |
WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6191165B1 (en) * | 1996-05-31 | 2001-02-20 | Allelix Neuroscience Inc. | Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
EP1014966B1 (en) * | 1996-05-31 | 2006-08-02 | Allelix Neuroscience Inc. | Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
-
2001
- 2001-06-15 DO DO2001000189A patent/DOP2001000189A/en unknown
- 2001-06-18 PA PA20018519901A patent/PA8519901A1/en unknown
- 2001-06-22 EP EP01940919A patent/EP1294677B1/en not_active Expired - Lifetime
- 2001-06-22 DE DE60106914T patent/DE60106914T2/en not_active Expired - Fee Related
- 2001-06-22 AU AU2001274407A patent/AU2001274407A1/en not_active Abandoned
- 2001-06-22 WO PCT/IB2001/001139 patent/WO2002000602A1/en active IP Right Grant
- 2001-06-22 PT PT01940919T patent/PT1294677E/en unknown
- 2001-06-22 ES ES01940919T patent/ES2230326T3/en not_active Expired - Lifetime
- 2001-06-22 JP JP2002505351A patent/JP3801561B2/en not_active Expired - Fee Related
- 2001-06-22 AT AT01940919T patent/ATE281427T1/en not_active IP Right Cessation
- 2001-06-22 DK DK01940919T patent/DK1294677T3/en active
- 2001-06-22 AP APAP/P/2001/002203A patent/AP2001002203A0/en unknown
- 2001-06-26 PE PE2001000625A patent/PE20020121A1/en not_active Application Discontinuation
- 2001-06-27 UY UY26802A patent/UY26802A1/en unknown
- 2001-06-28 AR ARP010103089A patent/AR033828A1/en unknown
- 2001-06-29 TN TNTNSN01098A patent/TNSN01098A1/en unknown
- 2001-07-02 US US09/897,261 patent/US6506780B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AP2001002203A0 (en) | 2001-09-30 |
EP1294677B1 (en) | 2004-11-03 |
PT1294677E (en) | 2005-01-31 |
US20020052401A1 (en) | 2002-05-02 |
TNSN01098A1 (en) | 2005-11-10 |
JP3801561B2 (en) | 2006-07-26 |
PA8519901A1 (en) | 2003-06-30 |
EP1294677A1 (en) | 2003-03-26 |
UY26802A1 (en) | 2002-01-31 |
WO2002000602A1 (en) | 2002-01-03 |
DK1294677T3 (en) | 2005-02-07 |
DE60106914T2 (en) | 2005-12-08 |
ES2230326T3 (en) | 2005-05-01 |
DOP2001000189A (en) | 2002-03-30 |
US6506780B2 (en) | 2003-01-14 |
JP2004501892A (en) | 2004-01-22 |
AR033828A1 (en) | 2004-01-07 |
PE20020121A1 (en) | 2002-02-16 |
DE60106914D1 (en) | 2004-12-09 |
ATE281427T1 (en) | 2004-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1055949A1 (en) | Benzophenones as inhibitors of il-1b and tnf-a | |
AU2001251136A1 (en) | Compositions and methods for promoting wound healing | |
AU2001249799A1 (en) | Platform for market programs and trading programs | |
AU2001249969A1 (en) | Inha inhibitors and their use as antibacterials | |
AU3398402A (en) | Prevention of preservative uptake into biomaterials | |
AU2001265052A1 (en) | Package kit and method | |
AU2002365396A1 (en) | Peptides, peptide compositions,and methods of use in binding p 185 | |
AU2001274407A1 (en) | Benzophenones and sulfones as inhibitors of glycine uptake | |
AU2001271266A1 (en) | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes | |
EP1300130A4 (en) | Gel composition and nail beautifier | |
WO2001091700A8 (en) | Composition and method for enhancing elasticity of tissue | |
AU2002246655A1 (en) | Compositions and methods for detecting proteolytic activity | |
AU2001245896A1 (en) | Maize glycine rich protein promoter compositions and methods for use thereof | |
AU2002221271A1 (en) | Improved shoe and last | |
AU2002332507A1 (en) | Levothyroxine compositions and methods | |
IL153276A0 (en) | Metalloprotease peptide substrates and methods | |
AU2003268078A1 (en) | Levothyroxine compositions and methods | |
AU2001293047A1 (en) | Human neprilysin protease | |
AU7057701A (en) | New use as antihelmintics of albofungin and analogs | |
AU2001282360A1 (en) | Kit of adhesion-release agents | |
AU2001293084A1 (en) | Human protease inhibitor proteins and polynucleotides encoding the same | |
AU2002362468A1 (en) | Levothyroxine compositions and methods | |
AU2001290586A1 (en) | Compositions and methods relating to hypertension | |
AU2001267093A1 (en) | Novel use of peptide | |
AU2001294635A1 (en) | Human protease inhibitor proteins and polynucleotides encoding the same |